Treatment of Bacterial Vaginosis (BV)
All women who have symptomatic bacterial vaginosis require treatment, while asymptomatic BV generally does not require treatment except in specific high-risk situations. 1
Diagnostic Criteria for BV
BV is diagnosed when at least three of the following four Amsel criteria are present:
Alternatively, Gram stain can be used to determine the relative concentration of bacterial morphotypes characteristic of BV 1, 2
Treatment Indications
Symptomatic BV
- All women with symptomatic BV require treatment, regardless of pregnancy status 1
- The principal goal of therapy is to relieve vaginal symptoms and signs of infection 1
Asymptomatic BV
- Generally, asymptomatic BV does not require treatment 1, 2
- Exceptions where treatment of asymptomatic BV is indicated:
- Before surgical abortion procedures to reduce post-abortion PID 1
- Before hysterectomy or other invasive gynecological procedures to reduce risk of postoperative infectious complications 1, 2
- High-risk pregnant women (those with history of preterm delivery) to potentially reduce risk of prematurity 1, 3
Treatment Regimens
First-Line Treatment Options
- Metronidazole 500 mg orally twice daily for 7 days (95% cure rate) 1, 4
- Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days 1, 4
- Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days 1, 4
Alternative Regimens
- Tinidazole 2g orally once daily for 2 days (FDA-approved for BV) 5
- Tinidazole 1g orally once daily for 5 days 5
- Metronidazole 2g orally in a single dose (lower efficacy at 84% compared to 7-day regimen) 4, 6
Special Considerations
Pregnancy
- All symptomatic pregnant women should be treated because BV is associated with adverse pregnancy outcomes including premature rupture of membranes, preterm labor, preterm birth, and postpartum endometritis 1, 4
- Oral metronidazole or clindamycin are recommended for pregnant women 1
- A follow-up evaluation one month after treatment completion is recommended for pregnant women to verify effectiveness 1
Important Clinical Considerations
- Patients using metronidazole should avoid alcohol during treatment and for 24 hours afterward due to potential disulfiram-like reaction 1
- Clindamycin cream is oil-based and might weaken latex condoms and diaphragms 2, 4
- Treatment of male sex partners has not been shown to prevent recurrence of BV and is not recommended 1
- Recurrence is common, with 50-80% of women experiencing recurrence within a year of treatment 7, 8
Clinical Pitfalls to Avoid
- Treating asymptomatic women unnecessarily exposes them to medication side effects without clear benefit 2, 4
- Failing to treat before invasive gynecological procedures may increase risk of post-procedure infections 1, 2
- Not recognizing that BV is associated with increased risk for acquiring STIs and HIV 1, 7
- Overlooking the high recurrence rate of BV after standard treatment, which may necessitate extended treatment regimens in some cases 7, 8